ストックスクリーナーアプリを入手
0.83
7.51%
0.058
アフターアワーズ：
2.58
1.75
+210.84%
前日終値:
$0.772
開ける：
$0.797
24時間の取引高:
283.56K
Relative Volume:
0.09
時価総額：
$8.41M
収益：
-
当期純損益:
$-1.13M
株価収益率:
-1.8079
EPS:
-0.4591
ネットキャッシュフロー:
$-4.60M
1週間 パフォーマンス:
+14.64%
1か月 パフォーマンス:
-31.97%
6か月 パフォーマンス:
-24.55%
1年 パフォーマンス:
-50.00%
1日の値動き範囲:
$0.772
$0.869
1週間の範囲:
$0.70
$0.869
52週間の値動き範囲:
$0.63
$1.90
Pharmacyte Biotech Inc Stock (PMCB) Company Profile
名前
Pharmacyte Biotech Inc
セクター
電話
(917) 595.2850
住所
3960 HOWARD HUGHES PARKWAY, LAS VEGAS
PMCB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 2.24 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
3.39 | 4.30B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.92 | 372.90M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
4.84 | 340.50M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
SHMD
Schmid Group N V
|
7.50 | 314.36M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
47.57 | 0 | 0 | 0 | 0 | 0.00 |
Pharmacyte Biotech Inc (PMCB) 最新ニュース
Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com
Pharmacyte Biotech CEO Silverman buys $80k in shares By Investing.com - Investing.com India
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232 By Investing.com - Investing.com UK
How institutional buying supports PharmaCyte Biotech Inc. stock2026 world cup usa national team qualification goalkeepers high defensive line odds analysis preview - ulpravda.ru
PharmaCyte Biotech Inc. (PMCB) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Largest borrow rate increases among liquid names - TipRanks
Will PharmaCyte Biotech Inc. stock benefit from infrastructure spending2025 Top Gainers & Weekly Breakout Watchlists - Улправда
Is PharmaCyte Biotech Inc. stock positioned for digital transformation2025 Trading Recap & Free Community Supported Trade Ideas - Улправда
Will PharmaCyte Biotech Inc. stock keep outperforming rivalsLong Setup & AI Forecasted Entry and Exit Points - DonanımHaber
How PharmaCyte Biotech Inc. stock reacts to job market dataJuly 2025 Pullbacks & Reliable Entry Point Trade Alerts - Улправда
How sustainable is PharmaCyte Biotech Inc. stock dividend payoutVolume Spike & Weekly Momentum Stock Picks - Улправда
Why PharmaCyte Biotech Inc. stock is a value investor pickShare Buyback & Expert Verified Stock Movement Alerts - Улправда
PharmaCyte Biotech, Inc. SEC 10-Q Report - TradingView — Track All Markets
Movement Recap: How sustainable is PharmaCyte Biotech Inc. stock dividend payoutJuly 2025 Chart Watch & Real-Time Stock Price Movement Reports - Улправда
PharmaCyte Biotech delays quarterly report filing - MSN
PharmaCyte Biotech Delays Quarterly Report Filing - TipRanks
PharmaCyte Biotech (PMCB) files notice of late Form 10-Q under Rule 12b-25 - Stock Titan
Dir Walker Surrenders 16,875 Of PharmaCyte Biotech Inc [PMCB] - TradingView — Track All Markets
PharmaCyte Biotech faces NASDAQ non-compliance notice - MSN
Healthy Upside Potential: PharmaCyte Biotech Inc (PMCB) - setenews.com
PharmaCyte’s Successful Stake Earns them Millions - StocksToTrade
PharmaCyte Biotech Faces Nasdaq Non-Compliance Notice - TipRanks
PharmaCyte Biotech’s Potential Explored Amidst Market Movements - timothysykes.com
PharmaCyte Boosts Financial Position with Femasys Stake Sale - timothysykes.com
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - MSN
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
Why PharmaCyte Biotech Inc. stock appeals to dividend seekers2025 Institutional Moves & Consistent Profit Trade Alerts - Newser
PharmaCyte Biotech (OTCMKTS:PMCBD) Trading Down 6.1% – Here’s What Happened - Defense World
Take off with PharmaCyte Biotech Inc (PMCB): Get ready for trading - Setenews
How does IO Biotech Inc (IOBT) change from a tortoise to a hare? - Setenews
Is PharmaCyte Biotech Inc a good long term investmentVolatility Adjusted Trading & High Profit Market Ideas - earlytimes.in
PharmaCyte Biotech stock surges following profitable exit from Femasys investment - MSN
PharmaCyte Biotech - The Pharma Letter
PharmaCyte Biotech successfully monetizes Femasys stake - The Pharma Letter
Check Out PharmaCyte Biotech Inc (PMCB)’s Trade Data Rather Than the Analysts’ Views - Setenews
A History of Outperforming Analyst Forecasts and Beating the Odds: Clean Energy Technologies Inc (CETY) - Setenews
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket - Benzinga
PharmaCyte Biotech (PMCB) Stock: Increases Cash and Securities to $20M Strengthening Balance Sheet - parameter.io
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million - Investing.com Nigeria
PharmaCyte Biotech stock soars after successful Femasys stake sale By Investing.com - Investing.com Australia
PharmaCyte Biotech stock soars after successful Femasys stake sale - Investing.com
Pharmacyte Biotech Inc (PMCB) 財務データ
収益
当期純利益
現金流量
EPS
28.63%
大文字化:
|
ボリューム (24 時間):